Predict your next investment

Asahi Kasei company logo
Holding Company
INDUSTRIALS | Basic Materials / Chemicals
asahi-kasei.co.jp

See what CB Insights has to offer

Investments

20

Portfolio Exits

4

Partners & Customers

10

About Asahi Kasei

Asahi Kasei provides solutions based in chemistry and materials science to a diverse range of markets including fibers, chemicals, consumer products, housing, construction, electronics, and health care. The company was founded in 1974 and is based in Tokyo, Japan.

Asahi Kasei Headquarter Location

1-105 Kanda Jinbocho, Chiyoda-ku

Tokyo, 101-8101,

Japan

+81-(0)3-3296-3000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Asahi Kasei

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Asahi Kasei in 1 Expert Collection, including Medical Devices.

M

Medical Devices

295 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

Asahi Kasei Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Asahi Kasei Rank

Latest Asahi Kasei News

Global Superdisintegrants Market Research Report to 2027 - Featuring Anshul Life Sciences, Asahi Kasei and Ashland Global Specialty Chemicals Among Others - ResearchAndMarkets.com

May 10, 2022

Global Superdisintegrants Market Research Report to 2027... Search jobs 10-May-2022 Global Superdisintegrants Market Research Report to 2027 - Featuring Anshul Life Sciences, Asahi Kasei and Ashland Global Specialty Chemicals Among Others - ResearchAndMarkets.com Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Superdisintegrants Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Superdisintegrants Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Superdisintegrants Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Superdisintegrants Market? 4. What is the competitive strategic window for opportunities in the Global Superdisintegrants Market? 5. What are the technology trends and regulatory frameworks in the Global Superdisintegrants Market? 6. What is the market share of the leading vendors in the Global Superdisintegrants Market? 7. What modes and strategic moves are considered suitable for entering the Global Superdisintegrants Market? Market Dynamics

Asahi Kasei Investments

20 Investments

Asahi Kasei has made 20 investments. Their latest investment was in Rege Nephro as part of their Series A - II on January 1, 2022.

CBI Logo

Asahi Kasei Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/31/2022

Series A - II

Rege Nephro

$12.06M

Yes

3

10/19/2021

Series A

HistoWiz

$32M

Yes

11

5/19/2021

Series C

Super Home

$50M

Yes

3

12/1/2020

Corporate Minority

Subscribe to see more

$99M

Subscribe to see more

10

9/9/2020

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/31/2022

10/19/2021

5/19/2021

12/1/2020

9/9/2020

Round

Series A - II

Series A

Series C

Corporate Minority

Series C

Company

Rege Nephro

HistoWiz

Super Home

Subscribe to see more

Subscribe to see more

Amount

$12.06M

$32M

$50M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

11

3

10

10

Asahi Kasei Portfolio Exits

4 Portfolio Exits

Asahi Kasei has 4 portfolio exits. Their latest portfolio exit was Rapid Micro Biosystems on July 16, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/16/2021

IPO

$99M

4

6/21/2018

IPO

Subscribe to see more

$99M

Subscribe to see more

10

11/13/2017

Divestiture

Subscribe to see more

Subscribe to see more

10

4/12/2002

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

Date

7/16/2021

6/21/2018

11/13/2017

4/12/2002

Exit

IPO

IPO

Divestiture

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

4

10

10

0

Asahi Kasei Acquisitions

11 Acquisitions

Asahi Kasei acquired 11 companies. Their latest acquisition was Bionova Scientific on April 18, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/18/2022

Private Equity

$99M

$13.3M

Acquired

3

12/15/2021

$99M

Acquired

3

3/4/2020

$99M

Acq - P2P

3

12/4/2018

Subscribe to see more

$99M

Subscribe to see more

10

7/19/2018

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/18/2022

12/15/2021

3/4/2020

12/4/2018

7/19/2018

Investment Stage

Private Equity

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$13.3M

Note

Acquired

Acquired

Acq - P2P

Subscribe to see more

Subscribe to see more

Sources

3

3

3

10

10

Asahi Kasei Partners & Customers

10 Partners and customers

Asahi Kasei has 10 strategic partners and customers. Asahi Kasei recently partnered with Genomatica on March 3, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

3/15/2022

Vendor

United States

Asahi Kasei to Accelerate Trials for Commercialization of Polyamide 66 Made Using Biomass-Derived Intermediate

NEW YORK & TOKYO -- -- Asahi Kasei , a diversified Japanese multinational company , has formed a strategic partnership with Genomatica , Inc. , regarding hexamethylenediamine based on biomass-derived raw material .

6

3/8/2022

Licensor

United States

ExThera Medical, Asahi Kasei Medical Forge Distribution Pact

`` ExThera Medical Corporation 's partnership with Asahi Kasei Medical is an important milestone in our collaborative ongoing fight against life threatening pathogens .

1

12/21/2021

Licensor

United States

ExThera Medical and Asahi Kasei Medical Enter into Partnership to Expand Reach of Treatment for the Critically Ill

`` ExThera Medical Corporation 's partnership with Asahi Kasei Medical is an important milestone in our collaborative ongoing fight against life threatening pathogens .

2

11/24/2021

Vendor

Netherlands

Subscribe to see more

Subscribe to see more

10

1/28/2021

Licensee

United States

Subscribe to see more

Subscribe to see more

10

Date

3/15/2022

3/8/2022

12/21/2021

11/24/2021

1/28/2021

Type

Vendor

Licensor

Licensor

Vendor

Licensee

Business Partner

Country

United States

United States

United States

Netherlands

United States

News Snippet

Asahi Kasei to Accelerate Trials for Commercialization of Polyamide 66 Made Using Biomass-Derived Intermediate

NEW YORK & TOKYO -- -- Asahi Kasei , a diversified Japanese multinational company , has formed a strategic partnership with Genomatica , Inc. , regarding hexamethylenediamine based on biomass-derived raw material .

ExThera Medical, Asahi Kasei Medical Forge Distribution Pact

`` ExThera Medical Corporation 's partnership with Asahi Kasei Medical is an important milestone in our collaborative ongoing fight against life threatening pathogens .

ExThera Medical and Asahi Kasei Medical Enter into Partnership to Expand Reach of Treatment for the Critically Ill

`` ExThera Medical Corporation 's partnership with Asahi Kasei Medical is an important milestone in our collaborative ongoing fight against life threatening pathogens .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

6

1

2

10

10

You May Also Like

U
UBE

UBE manufactures and develops chemicals, plastics, pharmaceuticals, machinery and metal products, cement, and construction materials. It is based in Gurgaon, India.

K
Kuraray

Kuraray provides chemical manufacturing production and sale of functional resins, chemical products, man-made leathers, synthetic fibers and textiles, optics-related products, and medical products. It is based in Tokyo, Japan.

M
Mitsui Chemicals

Mitsui Chemicals (TYO: 4183) manufactures petrochemicals, basic chemicals, polyurethanes, functional polymeric materials, functional chemicals, and films & sheets.

S
Shin-Etsu Chemical

Shin-Etsu Chemical (TYO: 4063) is a chemicals company that offers products including silicones, cellulose derivatives, fluorinated products/silica products, and more.

S
Sumitomo Chemical

Sumitomo Chemical has developed a number of plant protection chemicals, ranging from conventional insecticides, fungicides and herbicides to new types of products, including plant growth regulators.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.